Jul 27, 2026 08:00AM
Jul 21, 2026 08:02AM
Jul 21, 2026 08:00AM
Jul 15, 2026 08:00AM
May 27, 2026 08:00AM
Apr 21, 2026 08:00AM
Apr 20, 2026 08:00AM PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
Apr 16, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM
Jan 2, 2026 08:00AM
Dec 2, 2025 09:53AM
Nov 17, 2025 08:00AM PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM
Oct 8, 2025 08:00AM
Aug 27, 2025 08:00AM
Aug 14, 2025 08:02AM PharmaTher receives FDA approval for ketamine product KETARx
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM
Aug 11, 2025 09:49AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM
Mar 3, 2025 08:00AM PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 19, 2024 08:00AM
May 15, 2024 08:00AM
May 1, 2024 08:50AM
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM PharmaTher Holdings Provides Update for KETARX™ (Racemic Ketamine) Development Programs and Expected Milestones for 2023
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM
Sep 7, 2022 07:00AM PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™ Ketamine Patch
Jul 13, 2022 07:00AM

326,558 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All